![](/images/graphics-bg.png)
Role of the Microbiota and Antibiotics in Primary Sclerosing Cholangitis
Joint Authors
Tabibian, James H.
Talwalkar, Jayant A.
Lindor, Keith D.
Source
Issue
Vol. 2013, Issue 2013 (31 Dec. 2013), pp.1-7, 7 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2013-10-22
Country of Publication
Egypt
No. of Pages
7
Main Subjects
Abstract EN
Primary sclerosing cholangitis (PSC) is an idiopathic, progressive, cholestatic liver disease with considerable morbidity and mortality and no established pharmacotherapy.
In addition to the long-recognized association between PSC and inflammatory bowel disease, several lines of preclinical and clinical evidence implicate the microbiota in the etiopathogenesis of PSC.
Here we provide a concise review of these data which, taken together, support further investigation of the role of the microbiota and antibiotics in PSC as potential avenues toward elucidating safe and effective pharmacotherapy for patients afflicted by this illness.
American Psychological Association (APA)
Tabibian, James H.& Talwalkar, Jayant A.& Lindor, Keith D.. 2013. Role of the Microbiota and Antibiotics in Primary Sclerosing Cholangitis. BioMed Research International،Vol. 2013, no. 2013, pp.1-7.
https://search.emarefa.net/detail/BIM-1004171
Modern Language Association (MLA)
Tabibian, James H.…[et al.]. Role of the Microbiota and Antibiotics in Primary Sclerosing Cholangitis. BioMed Research International No. 2013 (2013), pp.1-7.
https://search.emarefa.net/detail/BIM-1004171
American Medical Association (AMA)
Tabibian, James H.& Talwalkar, Jayant A.& Lindor, Keith D.. Role of the Microbiota and Antibiotics in Primary Sclerosing Cholangitis. BioMed Research International. 2013. Vol. 2013, no. 2013, pp.1-7.
https://search.emarefa.net/detail/BIM-1004171
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1004171